<html>
<head>PUBMED IDs for FXYD3</head>
<body bgcolor='#C5F0F2'><h1>FXYD3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/16003754/'>FXYD3 is overexpressed in pancreatic ductal adenocarcinoma and influences pancreatic cancer cell growth.</a> July 9  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16288923/'>Correlation of gene and protein structures in the FXYD family proteins.</a> November 18  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16288911/'>Microarray analysis to evaluate different animal models for human heart failure.</a> November 18  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17077088/'>Structural and functional properties of two human FXYD3 (Mat-8) isoforms.</a> November 2  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/18494146/'>Changes in gene expression induced by polycyclic aromatic hydrocarbons in the human cell lines HepG2 and A549.</a> May 22  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19109419/'>A link between FXYD3 (Mat-8)-mediated Na,K-ATPase regulation and differentiation of Caco-2 intestinal epithelial cells.</a> April 14  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19789341/'>Immutable functional attributes of histologic grade revealed by context-independent gene expression in primary breast cancer cells.</a> December 16  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19893046/'>Down-regulation of FXYD3 expression in human lung cancers: its mechanism and potential role in carcinogenesis.</a> February 26  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19955746/'>Expression of FXYD3 protein in relation to biological and clinicopathological variables in colorectal cancers.</a> March 20  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20112499/'>FXYD3 expression in gliomas and its clinicopathological significance.</a> March 4  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20112494/'>Effect of Yikun Neiyi Wan on the expression of aromatase P450, COX-2, and ER related receptor in endometrial cells in vitro from patients with endometriosis.</a> February 24  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20805335/'>Translocation of Pseudomonas aeruginosa from the intestinal tract is mediated by the binding of ExoS to an Na,K-ATPase regulator, FXYD3.</a> November 13  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21288909/'>Structural analysis of the cancer-specific promoter in mesothelin and in other genes overexpressed in cancers.</a> July 20  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21372379/'>Down-regulation of FXYD3 is induced by transforming growth factor-β signaling via ZEB1/δEF1 in human mammary epithelial cells.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21499437/'>FXYD3: A Promising Biomarker for Urothelial Carcinoma.</a> April 19  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23534794/'>Gene expression profiling of intrahepatic cholangiocarcinoma.</a> December 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23534784/'>Construction and expression of an eukaryotic expression vector containing the IER3 gene.</a> December 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/26410457/'>FXYD1 negatively regulates Na(+)/K(+)-ATPase activity in lung alveolar epithelial cells.</a> September 23  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26740212/'>Silencing overexpression of FXYD3 protein in breast cancer cells amplifies effects of doxorubicin and γ-radiation on Na(+)/K(+)-ATPase and cell survival.</a> October 16  2016<br></body></html>
